Levosimendan Labatec 12.5 mg/5 ml

Levosimendan Labatec 12.5 mg/5 ml is a medicine authorised by Swissmedic under authorisation number 69551. The authorisation holder is Labatec Pharma SA. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 10 July 2024 and the authorisation is limited until 09 July 2029. ATC code C01CX08 places the medicine in the group Cardiac therapy.

  • Dispensing category A
  • Authorisation number 69551
  • ATC C01CX08
  • Synthetic medicines
Authorisation data
Authorisation number69551
NameLevosimendan Labatec 12.5 mg/5 ml
Full nameLevosimendan Labatec 12.5 mg/5 ml, solution à diluer pour perfusion
Authorisation holderLabatec Pharma SA
Medicinal product codeSynthetic medicines
Dispensing categoryA · Prescription, not repeatable
ATC codeC01CX08
First authorisation10 July 2024
Authorisation validity09 July 2029
Strengths
No.NameDispensing categoryAuthorisation date
1Levosimendan Labatec 12.5 mg/5 ml, solution à diluer pour perfusionA10 July 2024

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
11Durchstechflasche(n)C01CX0802.05.2.A

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Levosimendan Labatec 12.5 mg/5 ml authorised in Switzerland?

Yes. Levosimendan Labatec 12.5 mg/5 ml is authorised by Swissmedic under authorisation number 69551, data as of 01 September 2026. The authorisation is limited until 09 July 2029.

Which dispensing category does Levosimendan Labatec 12.5 mg/5 ml have?

Levosimendan Labatec 12.5 mg/5 ml is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.

Who is the authorisation holder of Levosimendan Labatec 12.5 mg/5 ml?

The authorisation holder is Labatec Pharma SA. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com